Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (‘SEBI Listing Regulations’), Brooks Laboratories has informed that the Board of Directors of the company at its meeting held on April 11, 2020, has considered; The Board has approved incorporation of wholly-owned subsidiary company by making investment of Rs 1,00,000 subject to compliance of applicable laws. The details as required under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFO/CMD/4/2015 dated 9th September, 2015 are as enclosed. The meeting of the Board of Directors commenced at 4.00 pm and concluded at 4.20 pm.
The above information is a part of company’s filings submitted to BSE.
